fbpx
February 28, 2025

FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use

FDA reviewed five observational studies4-8 and two meta-analyses of placebo-controlled trials9,10 to examine the risk of cardiovascular events associated with testosterone replacement therapy (TRT). The five […]
February 28, 2025

FDA Roundup: February 28, 2025

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, […]
February 27, 2025

Pathways for Students and Recent Graduates

Pathways Program for Students and Recent Graduates The Pathways Program offers federal internship and employment opportunities for current students, recent graduates, and those with an advanced […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0